Furthermore, the amount of ctDNA shed into the blood depends on the type of tumor, a concept known as tumor-shedding, which influences the ctDNA detection rate; in advanced BRAF-mutant melanoma, it is reported to be around 80%. Here, BRAF is linked to melanoma.